Foley Partners Lawrence M. Kraus and Judith A. Waltz, along with Senior Counsel Richard K. Rifenbark, discussed what health care entities need to know about the False Claims Act (FCA) amendments. Topics included:
- Overview and mechanics of FCA
- Role of the whistleblower in bringing FCA cases
- Recent statistics on FCA lawsuits and settlements
- Analysis of recent amendments to the FCA and the intended purpose of the amendments
- Potential implications of the FCA amendments for health care entities
People
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.